British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump’s possible tariffs on the sector. Other pharmaceutical companies have also announced plans to increase investments in the United States.
Despite soaring gold prices reaching historic highs, jewelers anticipate healthy demand this Akshaya Tritiya, driven by lighter, more affordable ornaments. The industry is adapting with […]
NCLT has ordered the liquidation of GoAir after lenders’ request as the airline, grounded since May 2023, failed to revive under insolvency laws. GoAir owes […]
